According to Hawkins's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.74952. At the end of 2023 the company had a P/S ratio of 1.60.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.60 | 82.89% |
2022 | 0.8725 | -24.24% |
2021 | 1.15 | 19.17% |
2020 | 0.9664 | 8.18% |
2019 | 0.8933 | 13.03% |
2018 | 0.7903 | 4.39% |
2017 | 0.7571 | -34.62% |
2016 | 1.16 | 16.69% |
2015 | 0.9922 | -22.88% |
2014 | 1.29 | 15% |
2013 | 1.12 | -4.42% |
2012 | 1.17 | 4.78% |
2011 | 1.12 | -32.91% |
2010 | 1.66 | 93.87% |
2009 | 0.8588 | 46.68% |
2008 | 0.5855 | -29.5% |
2007 | 0.8305 | -10.65% |
2006 | 0.9295 | -10.62% |
2005 | 1.04 | -6.11% |
2004 | 1.11 | -15.8% |
2003 | 1.32 | 49.61% |
2002 | 0.8792 | 5.51% |
2001 | 0.8333 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Albemarle ALB | 1.41 | -19.69% | ๐บ๐ธ USA |
FMC FMC | 1.61 | -8.09% | ๐บ๐ธ USA |
Marrone Bio Innovations
MBII | 3.28 | 87.76% | ๐บ๐ธ USA |
Quaker Houghton KWR | 1.73 | -1.32% | ๐บ๐ธ USA |
American Vanguard AVD | 0.5646 | -67.73% | ๐บ๐ธ USA |
Adicet Bio ACET | N/A | N/A | ๐บ๐ธ USA |